USD 13.94
(-0.43%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 211.5 Million USD | 21.63% |
2022 | 173.88 Million USD | -4.29% |
2021 | 181.68 Million USD | -7.17% |
2020 | 195.72 Million USD | 3.84% |
2019 | 188.48 Million USD | 26.76% |
2018 | 148.69 Million EUR | 18.03% |
2017 | 125.98 Million EUR | 20.99% |
2016 | 104.12 Million EUR | -2.74% |
2015 | 107.05 Million EUR | 50.62% |
2014 | 71.08 Million EUR | -12.5% |
2013 | 81.22 Million EUR | -21.95% |
2012 | 104.06 Million EUR | -8.85% |
2011 | 114.17 Million EUR | -2.75% |
2010 | 117.4 Million EUR | 8.79% |
2009 | 107.91 Million EUR | -13.15% |
2008 | 124.25 Million EUR | -13.46% |
2007 | 143.58 Million EUR | -5.65% |
2006 | 152.18 Million EUR | -1.68% |
2005 | 154.78 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 260.81 Million USD | 0.0% |
2023 Q4 | 211.5 Million USD | 0.08% |
2023 Q2 | 178.31 Million USD | -3.91% |
2023 Q1 | 185.56 Million EUR | 6.72% |
2023 FY | 211.5 Million USD | 21.63% |
2023 Q3 | 211.33 Million EUR | 18.52% |
2022 Q2 | 193.73 Million EUR | -7.17% |
2022 Q3 | 165.8 Million EUR | -14.42% |
2022 FY | 173.88 Million USD | -4.29% |
2022 Q4 | 173.88 Million USD | 4.88% |
2022 Q1 | 208.68 Million EUR | 14.86% |
2021 Q2 | 191.65 Million EUR | -0.21% |
2021 Q1 | 192.06 Million EUR | -2.31% |
2021 Q3 | 188.72 Million EUR | -1.53% |
2021 FY | 181.68 Million USD | -7.17% |
2021 Q4 | 181.68 Million EUR | -3.73% |
2020 Q4 | 196.59 Million EUR | 3.4% |
2020 Q1 | 192.27 Million EUR | 2.01% |
2020 FY | 195.72 Million USD | 3.84% |
2020 Q2 | 195.95 Million EUR | 1.91% |
2020 Q3 | 190.12 Million EUR | -2.98% |
2019 Q4 | 188.48 Million EUR | 2.98% |
2019 FY | 188.48 Million USD | 26.76% |
2019 Q3 | 183.03 Million EUR | -1.19% |
2019 Q2 | 185.24 Million EUR | 1.52% |
2019 Q1 | 182.46 Million EUR | 40.28% |
2018 Q2 | 131.42 Million EUR | -18.82% |
2018 FY | 148.69 Million EUR | 18.03% |
2018 Q3 | 151 Million EUR | 14.9% |
2018 Q1 | 161.89 Million EUR | 54.31% |
2018 Q4 | 130.07 Million EUR | -13.86% |
2017 Q3 | 124 Million EUR | 21.22% |
2017 Q2 | 102.29 Million EUR | -6.27% |
2017 Q1 | 109.13 Million EUR | 10.55% |
2017 FY | 125.98 Million EUR | 20.99% |
2017 Q4 | 104.91 Million EUR | -15.39% |
2016 Q3 | 110.89 Million EUR | 5.85% |
2016 Q2 | 104.76 Million EUR | -12.19% |
2016 Q1 | 119.32 Million EUR | 21.07% |
2016 FY | 104.12 Million EUR | -2.74% |
2016 Q4 | 98.72 Million EUR | -10.97% |
2015 Q3 | 85.75 Million EUR | -5.74% |
2015 FY | 107.05 Million EUR | 50.62% |
2015 Q1 | 82.74 Million EUR | 16.41% |
2015 Q4 | 98.55 Million EUR | 14.92% |
2015 Q2 | 90.97 Million EUR | 9.95% |
2014 Q4 | 71.08 Million EUR | -6.72% |
2014 Q2 | 77.67 Million EUR | 10.67% |
2014 Q1 | 70.18 Million EUR | -13.6% |
2014 Q3 | 76.19 Million EUR | -1.9% |
2014 FY | 71.08 Million EUR | -12.5% |
2013 Q3 | 90.84 Million EUR | -6.33% |
2013 Q2 | 96.98 Million EUR | -2.05% |
2013 Q4 | 81.22 Million EUR | -10.58% |
2013 Q1 | 99.01 Million EUR | -4.86% |
2013 FY | 81.22 Million EUR | -21.95% |
2012 Q1 | 112.8 Million EUR | -1.21% |
2012 FY | 104.06 Million EUR | -8.85% |
2012 Q4 | 104.06 Million EUR | -5.79% |
2012 Q3 | 110.46 Million EUR | -5.59% |
2012 Q2 | 117.01 Million EUR | 3.73% |
2011 FY | 114.17 Million EUR | -2.75% |
2011 Q3 | 115.07 Million EUR | -4.74% |
2011 Q2 | 120.79 Million EUR | 5.16% |
2011 Q1 | 114.86 Million EUR | -2.16% |
2011 Q4 | 114.17 Million EUR | -0.78% |
2010 Q3 | 116.27 Million EUR | -7.46% |
2010 Q1 | 117.92 Million EUR | 9.28% |
2010 FY | 117.4 Million EUR | 8.79% |
2010 Q4 | 117.4 Million EUR | 0.97% |
2010 Q2 | 125.65 Million EUR | 6.56% |
2009 FY | 107.91 Million EUR | -13.15% |
2009 Q4 | 107.91 Million EUR | 0.0% |
2008 FY | 124.25 Million EUR | -13.46% |
2007 FY | 143.58 Million EUR | -5.65% |
2006 FY | 152.18 Million EUR | -1.68% |
2005 FY | 154.78 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Science to Consumers, Inc. | - USD | -Infinity% |
Bemax Inc. | 816.02 Thousand USD | -25818.686% |
Bruush Oral Care Inc. | 2.59 Million USD | -8053.768% |
CCA Industries, Inc. | 1.69 Million USD | -12407.734% |
DSwiss, Inc. | 311.07 Thousand USD | -67889.912% |
EOS, Inc. | 1.56 Million USD | -13450.728% |
Greyson International, Inc. | 824.27 Thousand USD | -25559.145% |
Happy Town Holdings Inc. | - USD | -Infinity% |
Horrison Resources Inc. | 17.75 USD | -1191558536.62% |
Infusion Brands International, Inc. | 29.09 Million USD | -626.87% |
Mandom Corporation | 132.5 Million USD | -59.612% |
Naples Soap Company Inc. | - USD | -Infinity% |
Emo Capital Corp. | 64.28 Thousand USD | -328911.353% |
Oliveda International, Inc. | 3.78 Million USD | -5487.47% |
PacificHealth Laboratories, Inc. | 660.06 Thousand USD | -31942.744% |
Prosperous Future Holdings Limited | 22.67 Million USD | -832.742% |
PURE Bioscience, Inc. | 3.68 Million USD | -5644.206% |
PayChest, Inc. | - USD | -Infinity% |
Skinvisible, Inc. | 9.18 Million USD | -2202.457% |
Sentient Brands Holdings Inc. | 2.11 Million USD | -9889.197% |
Sunset Capital Assets, Inc. | 830.25 Thousand USD | -25374.27% |
The Stephan Co. | 1.93 Million USD | -10830.318% |
Turner Valley Oil & Gas, Inc. | 329.77 Thousand USD | -64035.14% |
Winning Brands Corporation | 3.76 Million USD | -5513.605% |
Warpaint London PLC | 23.19 Million USD | -811.678% |
Zoono Group Limited | 1.83 Million USD | -11426.309% |
Zurvita Holdings, Inc. | 11.29 Million USD | -1772.532% |